ANTIFIBROTIC AGENT, AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES HAVING ANTIFIBROTIC ACTION

An object of the present invention is to provide a therapeutic preparation composed of a population of extracellular vesicles having a high therapeutic effect, particularly to provide an anti-fibrosis agent. The present invention relates to the anti-fibrosis agent containing a mesenchymal stem cell-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YAMANE Masayuki, ISHIDOME Takamasa
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YAMANE Masayuki
ISHIDOME Takamasa
description An object of the present invention is to provide a therapeutic preparation composed of a population of extracellular vesicles having a high therapeutic effect, particularly to provide an anti-fibrosis agent. The present invention relates to the anti-fibrosis agent containing a mesenchymal stem cell-derived extracellular vesicle, as an active ingredient, in which an extracellular vesicle is obtained by a method of using a substance that contains an extracellular vesicle having an affinity for phosphatidylserine, or/and an extracellular vesicle is derived from a mesenchymal stem cell stimulated with fibroblast growth factor, and relates to a method of producing an extracellular vesicle as the anti-fibrosis agent.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4091617A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4091617A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4091617A13</originalsourceid><addsrcrecordid>eNrjZIhz9AvxdPN0CvIP8XRWcHR39QvRUXD0c1HwdQ3x8HdRcPMPUggI8ncJdfb0c1dwjQgJcnR29fEJ9XEMUghzDfZ09nENVvBwDAPJohrlHOLp78fDwJqWmFOcyguluRkU3FxDnD10Uwvy41OLCxKTU_NSS-JdA0wMLA3NDM0dDY2JUAIAvGMykw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIFIBROTIC AGENT, AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES HAVING ANTIFIBROTIC ACTION</title><source>esp@cenet</source><creator>YAMANE Masayuki ; ISHIDOME Takamasa</creator><creatorcontrib>YAMANE Masayuki ; ISHIDOME Takamasa</creatorcontrib><description>An object of the present invention is to provide a therapeutic preparation composed of a population of extracellular vesicles having a high therapeutic effect, particularly to provide an anti-fibrosis agent. The present invention relates to the anti-fibrosis agent containing a mesenchymal stem cell-derived extracellular vesicle, as an active ingredient, in which an extracellular vesicle is obtained by a method of using a substance that contains an extracellular vesicle having an affinity for phosphatidylserine, or/and an extracellular vesicle is derived from a mesenchymal stem cell stimulated with fibroblast growth factor, and relates to a method of producing an extracellular vesicle as the anti-fibrosis agent.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221123&amp;DB=EPODOC&amp;CC=EP&amp;NR=4091617A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221123&amp;DB=EPODOC&amp;CC=EP&amp;NR=4091617A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAMANE Masayuki</creatorcontrib><creatorcontrib>ISHIDOME Takamasa</creatorcontrib><title>ANTIFIBROTIC AGENT, AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES HAVING ANTIFIBROTIC ACTION</title><description>An object of the present invention is to provide a therapeutic preparation composed of a population of extracellular vesicles having a high therapeutic effect, particularly to provide an anti-fibrosis agent. The present invention relates to the anti-fibrosis agent containing a mesenchymal stem cell-derived extracellular vesicle, as an active ingredient, in which an extracellular vesicle is obtained by a method of using a substance that contains an extracellular vesicle having an affinity for phosphatidylserine, or/and an extracellular vesicle is derived from a mesenchymal stem cell stimulated with fibroblast growth factor, and relates to a method of producing an extracellular vesicle as the anti-fibrosis agent.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIhz9AvxdPN0CvIP8XRWcHR39QvRUXD0c1HwdQ3x8HdRcPMPUggI8ncJdfb0c1dwjQgJcnR29fEJ9XEMUghzDfZ09nENVvBwDAPJohrlHOLp78fDwJqWmFOcyguluRkU3FxDnD10Uwvy41OLCxKTU_NSS-JdA0wMLA3NDM0dDY2JUAIAvGMykw</recordid><startdate>20221123</startdate><enddate>20221123</enddate><creator>YAMANE Masayuki</creator><creator>ISHIDOME Takamasa</creator><scope>EVB</scope></search><sort><creationdate>20221123</creationdate><title>ANTIFIBROTIC AGENT, AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES HAVING ANTIFIBROTIC ACTION</title><author>YAMANE Masayuki ; ISHIDOME Takamasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4091617A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>YAMANE Masayuki</creatorcontrib><creatorcontrib>ISHIDOME Takamasa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAMANE Masayuki</au><au>ISHIDOME Takamasa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIFIBROTIC AGENT, AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES HAVING ANTIFIBROTIC ACTION</title><date>2022-11-23</date><risdate>2022</risdate><abstract>An object of the present invention is to provide a therapeutic preparation composed of a population of extracellular vesicles having a high therapeutic effect, particularly to provide an anti-fibrosis agent. The present invention relates to the anti-fibrosis agent containing a mesenchymal stem cell-derived extracellular vesicle, as an active ingredient, in which an extracellular vesicle is obtained by a method of using a substance that contains an extracellular vesicle having an affinity for phosphatidylserine, or/and an extracellular vesicle is derived from a mesenchymal stem cell stimulated with fibroblast growth factor, and relates to a method of producing an extracellular vesicle as the anti-fibrosis agent.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4091617A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title ANTIFIBROTIC AGENT, AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES HAVING ANTIFIBROTIC ACTION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T14%3A28%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAMANE%20Masayuki&rft.date=2022-11-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4091617A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true